Clinical Evaluation of Tofisopam (Grandaxin) on Several Dermatological Diseases in Patients with Psychosomatic Symptoms.

DOI

Bibliographic Information

Other Title
  • 皮膚科領域における自律神経調節剤トフィソパム（グランダキシン）の使用経験

Search this article

Description

The clinical evaluation for tofisopam (GrandaxinR), a known regulator forautonomic nervous system, on severaldermatological diseases in patients withvarious psychosomatic symptoms was performedin open trial (chronic urticaria, 3 cases;pruritus cutaneus, 2 cases; hyperhidrosis, 4cases; alopecia areata, 2 cases, post-herpeticneuralgia, 1 case). The final global improvementwas 100% in urticaria and 50% inpruritus cutaneus, hyperhidrosis and alopecia areata. The effect on postherpetic neuralgiawas slight. Side effect was observed in onlyone case. In conclusion, tofisopam (GrandaxinR) can be regarded to be useful in the field of dermatology.

Journal

  • Skin research

    Skin research 33 (6), 699-707, 1991

    Meeting of Osaka Dermatological Association

Keywords

Details 詳細情報について

  • CRID
    1390001204799534080
  • NII Article ID
    130003843813
  • DOI
    10.11340/skinresearch1959.33.699
  • ISSN
    1884541X
    00181390
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top